This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.
Abstract Details
Activity Number:
|
583
|
Type:
|
Contributed
|
Date/Time:
|
Wednesday, August 4, 2010 : 2:00 PM to 3:50 PM
|
Sponsor:
|
Biopharmaceutical Section
|
Abstract - #308034 |
Title:
|
Case Study: Benefits of an Adaptive Clinical Trial Design in Oncology
|
Author(s):
|
Darcy Hille*+ and Christine K. Gause and Jason B. Clark and Sarah Hoagey and Keaven M. Anderson
|
Companies:
|
Merck & Co., Inc. and Merck Research Laboratories and Merck Research Laboratories and Merck & Co., Inc. and Merck Research Laboratories
|
Address:
|
UG1C-46, North Wales, PA, 19454,
|
Keywords:
|
adaptive trial design ;
interim analysis ;
oncology
|
Abstract:
|
Adaptive clinical trial designs are thought to offer benefits in terms of reduced cycle times, number of patients, and costs compared to classical designs, but this has yet to be fully established. This is a case study of a Phase II clinical study to evaluate an anticancer chemotherapy. As part of an adaptive design strategy, the study includes three interim analyses for futility. Statistical simulations were conducted to evaluate the performance of the design, which included estimating the probability of stopping at each interim analysis. The adaptive design was compared to the classical alternative which would not have futility analyses. Initial estimates showed benefits for the adaptive design with a reduced cycle time of 15 months, number of patients of 121, and grant costs of $3.8 million, all adjusted for the probability of stopping at each interim analysis.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2010 program
|
2010 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.